Biodesix, Inc.
BDSX
$15.86
$0.563.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 32.10% | 8.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 32.10% | 8.74% | |||
| Cost of Revenue | 18.83% | 1.86% | |||
| Gross Profit | 35.18% | 10.48% | |||
| SG&A Expenses | 5.79% | -3.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.63% | -3.03% | |||
| Operating Income | 72.09% | 27.33% | |||
| Income Before Tax | 54.34% | 24.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 54.34% | 24.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.34% | 24.00% | |||
| EBIT | 72.09% | 27.33% | |||
| EBITDA | 89.73% | 31.73% | |||
| EPS Basic | 57.53% | 25.69% | |||
| Normalized Basic EPS | 57.51% | 25.57% | |||
| EPS Diluted | 57.53% | 25.69% | |||
| Normalized Diluted EPS | 57.51% | 25.57% | |||
| Average Basic Shares Outstanding | 7.53% | 2.28% | |||
| Average Diluted Shares Outstanding | 7.53% | 2.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||